K-V Pharmaceutical, a fully-integrated specialty pharmaceutical company, has promoted Thomas McHugh to chief financial officer (CFO). McHugh joined in January 2009 as vice president of finance and corporate controller. He served as the company’s interim CFO from September 2009 until April 2010 and as the chief accounting officer (CAO) since February 2010. He possesses over 20 years of financial management expertise in the areas of regulatory and government compliance, internal and external financial reporting, investor relations, mergers and acquisitions and global finance.
Prior to joining K-V, McHugh was managing director – global and corporate controller with Bearing Point from 2005 to 2008; vice president of finance, CFO, treasurer and CAO with Huttig Building Products from 2000 to 2005; and corporate controller and CAO with XTRA Corporation from 1993 to 2000. McHugh began his professional career with PricewaterhouseCoopers (PwC) from 1990 to 1993, where he earned his certified public accountant (CPA).
McHugh received his BS in Finance from Bentley College and an MS in Accounting from the Graduate School of Professional Accounting at Northeastern University.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.